Clinical Trial Detail

NCT ID NCT04230109
Title Sacituzumab Govitecan In TNBC (NeoSTAR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aditya Bardia
Indications

triple-receptor negative breast cancer

Therapies

Sacituzumab govitecan-hziy

Age Groups: senior adult

No variant requirements are available.